NEW
YORK, May 15, 2024 /PRNewswire/ -- The
global cell therapy market size is estimated to grow by
USD 31041.49 million from 2023-2027,
according to Technavio. The market is estimated to grow at a CAGR
of 57.06% during the forecast period.
For more insights on the forecast market size and
historic data (2017 - 2021) - Download
Free sample report in a minutes
Forecast
period
|
2023-2027
|
Base Year
|
2022
|
Historic
Data
|
2017 - 2021
|
Segment
Covered
|
Type (Autologous and
Allogenic ), Application (Malignancies, Musculoskeletal,
Cardiovascular, and Others ), and Geography (North America, Europe,
Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Astellas Pharma Inc.,
Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA,
Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co.,
Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed
Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead
Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics
Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower
Group Co. Ltd., and ThermoGenesis Holdings Inc.
|
Key Market Trends Fueling Growth
The cell therapy market encompasses various disease areas,
including chronic heart failure, cancer, and diabetes. Novel
treatments utilize progenitor cells, adult and embryonic stem
cells, and iPS cells. While wound and dermal grafts dominate the
market, cancer treatments are limited, with PROVENGE, an autologous
cell therapy for cancer, being the first FDA-approved product.
Autologous cell therapies are under development by Novartis and
Opexa. Cell therapy research also explores gene therapies,
precision medicine, and individual differences in treatment
responses. Global population growth, climate change, and virus
outbreaks necessitate advancements in this field. Cell biology
research, stem cell therapies, and insulin-dependent diabetes are
key focus areas. Automation, genetic editing tools like
CRISPR-Cas9, and regulatory bodies such as the EMA and CAR-T
therapies are shaping the market's evolution. Funding, guidelines,
and cell banking facilities are crucial components, with EU grants
and Horizon Europe supporting research in this sector.
Market Challenges
- Cell therapy market primarily focuses on the development of
innovative treatments for various chronic conditions, including
diabetes, cancer, and genetic disorders. Clinical trials for these
products predominantly take place in high-income countries, with
costs reaching up to USD1.5 billion
from preclinical stages to approval. Factors such as dosing,
delivery, toxicity, and immune response are rigorously tested. Key
aspects include survival, quality control, cell banking, cell
types, funding, guidelines, and regulatory bodies like the European
Medicines Agency (EMA) and the US Food and Drug Administration
(FDA). Technological advancements in automation, genetic editing
tools like CRISPR-Cas9, and novel therapeutic regimes are driving
market growth. Key areas of interest include oncology, stem cell
therapy, and personalized medicine. Notable segments include
insulin-dependent diabetes, multiple myeloma, and acute lymphocytic
leukemia. Companies seek funding from EU grants, Horizon Europe,
and private investors to bring these life-changing therapies to
market.
Research report provides comprehensive data on
impact of trend, driver and challenges - Buy
Report
Segment Overview
This cell therapy market report extensively covers market
segmentation by
- Type
- 1.1 Autologous
- 1.2 Allogenic
- Application
- 2.1 Malignancies
- 2.2 Musculoskeletal
- 2.3 Cardiovascular
- 2.4 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Autologous- The cell therapy market segmentation
by type encompasses various applications, including acute
lymphocytic leukemia and chronic conditions such as diabetes and
multiple myeloma. The market growth in this sector is influenced by
factors like clinical studies in regenerative medicine and the
development of novel products. The segment exhibits a medium pace
due to manufacturing complexities and less established clinical
evidence. In contrast, allogeneic therapies, which do not rely on
individual cells, are preferred in emergency care. The cell therapy
market is driven by advancements in cell biology research, stem
cell therapies, and gene therapies. Precision medicine and
individual differences in disease mechanisms and progression
necessitate drug selection tailored to specific populations. Global
population growth, climate change, and virus outbreaks further fuel
the market's expansion. Pharmaceutical and biotechnology companies
invest heavily in cell therapy research, focusing on quality
control, cell banking facilities, and storage. Clinical trials are
underway to improve treatment responses and reduce complications,
such as immune response and immunosuppressive therapies. EU grants
and initiatives like Horizon Europe support these efforts,
promoting personalized medicine and stem cell therapy. Key players
in the cell therapy market include Panacell Biotech, Cellino
Biotech, Achilles Therapeutics, and Sernova. These companies
contribute significantly to the development and commercialization
of cell therapies, addressing various diseases and disorders.
For more information on market segmentation with geographical
analysis including forecast (2023-2027) and historic data (2017 -
2021) - Download a Sample Report
Research Analysis
The Cell Therapy Market encompasses the development, production,
and application of novel therapies derived from cell biology
research. These therapies aim to address various diseases and their
mechanisms, including disease progression and treatment responses.
The global population growth and climate change have increased the
demand for advanced treatments, leading to a surge in funding for
research in this field. Horizon Europe, a significant funding source, supports
initiatives in areas such as pneumonia, diabetes, and chronic
conditions. Cell banking facilities provide essential storage
solutions for cell types used in allogeneic therapies, ensuring
their availability for clinical trials and clinical studies.
Pharmaceutical and biotechnology companies invest heavily in
regenerative medicine to deliver effective treatments for virus
outbreaks and other chronic conditions. Grants and guidelines play
a crucial role in facilitating research and ensuring ethical
standards are met. Achilles Therapeutics and other innovators in
this sector are pioneering new approaches to cell therapy,
contributing to the advancement of this dynamic and evolving
market.
Market Research Overview
The Cell Therapy Market refers to the global industry focused on
the development, production, and application of cell therapies.
These therapies involve the use of living cells to treat or prevent
diseases and injuries. The market encompasses various types of cell
therapies, including stem cell therapy, gene therapy,
and immunotherapy. The market is driven by the increasing
prevalence of chronic diseases, technological advancements, and
regulatory approvals. The global cell therapy market is segmented
by application areas, such as oncology, neurology, and regenerative
medicine. The market is expected to grow significantly due to the
increasing demand for personalized medicine and the potential of
cell therapies to offer cure and improvement in quality of life for
patients. The market is also influenced by the challenges of
manufacturing and delivering these complex therapies at scale and
affordability.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Type
-
- Application
-
- Malignancies
- Musculoskeletal
- Cardiovascular
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cell-therapy-market-size-is-set-to-grow-by-usd-31041-49-million-from-2023-2027--limitations-in-traditional-organ-transplantations-fueling-demand-for-cell-therapies-to-boost-the-market-growth-technavio-302145161.html
SOURCE Technavio